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5 년의 시간 동안 많은 것을 배운 것 같습니다. 무엇보다도
박사학위 동안 연구 자체에 대한 열정을 잃지 않도록 해주신
주님께 감사드립니다. 실패에 좌절하는 저를 다시 일으켜 주시고
항상 겸손하는 마음을 잃지 않도록 지지해 주셔서 감사합니다.
연세대학교와 한국 과학 기술 연구원의 학연생으로서 남들과는
조금은 다른 좀 더 폭넓은 학위 생활을 했던 것 같습니다. 좋은
연구주제를 가지고 자유롭게 연구에만 몰입할 수 있게 든든한
지도를 해주신 박종철 교수님, 서준교 박사님 진심으로 감사합니다. 
찾아 뵐 때마다 항상 따뜻하게 저의 이야기를 들어 주시고 조언해
주신 박종철 교수님 덕분에 마음의 용기를 얻었습니다. 그리고
항상 꼼꼼하게 지도 뿐 만 아니라 좋은 연구자가 될 수 있도록
기회를 열어주신 서준교 박사님, 저에게 박사님의 마지막 제자가
될 영광을 주셔서 진심으로 감사합니다.
학위를 하는 동안 많은 깨우침을 주신 훌륭하신 분들을 많이
만났습니다. 먼저 저의 심사위원이신 김철훈 교수님, 정호성
교수님 좋은 조언을 해주셔서 감사합니다. 항상 친절하게 다양한
분야의 연구 영역에 접근할 수 있도록 기회를 주신 전누리 교수님,  
그리고 연구라는 열정을 다시 한 번 새롭게 느끼게 해주신 허은미
박사님, 지금도 항상 많은 것을 배웁니다. 감사합니다. 바이오닉스
연구단에 있는 동안 좋은 인격을 지니신 박사님을 많이 만났습니다. 
뒤에서 따뜻하게 저의 연구를 지지해 주셨던 김진석 박사님, 
졸업을 앞 둔 지금 저의 기억에 자리 잡은 좋은 박사님 이십니다. 
묵묵히 저를 응원해 주신 신현준 박사님, 윤인찬 박사님께도
진심으로 감사합니다.
바이오닉스 연구단은 인격이 훌륭하신 박사님들 뿐 만 아니라  
이를 따르는 좋은 학생들도 많았습니다. 우선 열정 가득한 성희씨, 
강일오빠 지금처럼 열정 가득한 모습으로 나중에 같이 연구할 수
있는 날을 기다려봅니다. 그리고 키스트에서 휴식처 같은 동휘오빠, 
많은 이야기를 나누진 못했지만 인사만으로도 공감할 수 있었던
민경씨 앞으로 좋은 연구 하셔서 뜻깊은 마무리 하시길 바랍니다.  
이 뿐만 아니라 동훈씨, 헌휘씨, 진기, 병성이에게도 감사함을
표합니다.  
그리고 자주 만나지 못하지만 만날 때마다 항상 반겨주는
학교동료인 민성오빠, 병주, 민아, 경미, 혜진, 그리고 항상 좋은
조언을 해주신  미희 언니 감사합니다.
저의 연구는 이 분들이 없었다면 결코 완성할 수 없었습니다. 처음
연구의 시작을 함께 했던 나라, 짧은 시간이지만 함께 했던 자윤, 
인생의 즐거움까지 느끼게 해준 라마와 가비, 그리고 마지막까지
함께 해준 연지에게 깊은 감사함을 전합니다. 바쁜 실험 일정도
묵묵히 견뎌내고 실패에 빠졌을 때 저에게 새로운 시각으로 연구를
접근할 수 있도록 해준 동료 덕분에 용기를 잃지 않았습니다.  
그리고 보윤 선생님, 키스트에서 좋은 벗을 만났습니다. 
감사합니다. 
무엇보다도 좋은 연구를 할 수 있었던 것은 저를 정신적으로
지지해준 사람이 있어서 가능 하였습니다. 항상 기도로 지지하고
응원해준 은숙 이모, 앞으로도 겸손함 잃지 않겠습니다. 묵묵히
저의 이야기를 들어주고 용기를 준 환이에게도 감사함을 전합니다.
마지막으로 언제나 저를 지지해 주는 가족..힘들 때 마다 누구보다
같이 걱정해 주고 가장 먼저 기뻐해 주는 가족이 있어서 저는
학위에 몰두할 수 있었습니다. 특히 석사과정부터 박사과정까지
오랜 기간 동안 저를 지켜주신 아버지 형만욱님과 어머니 정송자님, 
진심으로 감사하고 그리고 사랑합니다.  
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1Abstract
Axon generation and myelination in motor neuron-Schwann 
cell coculture model
Sujin Hyung
Department of Medical Science
The Graduate School, Yonsei University
(Directed by Professor Jong-Chul Park)
Myelination in the nervous system is an important structural element to 
electrically insulate the axon for the propagation of action potential with 
increased conduction velocity. In the peripheral nervous system (PNS), 
each Schwann cell corresponds with one internode in myelin sheath that 
is essential for the maintenance of propriety and functions of peripheral 
nerves. However, the deficiency of peripheral nerves in both disease and 
2injury model still remains unsolved and studies to recover this limitation 
have been performed in vivo as well as in vitro. Here, we successfully 
constructed 2-D and 3-D models of the motor nervous system. We first 
constructed 2-D MN-SC coculture on coverslip to understand 
interactions between MNs and SCs, and then developed 3-D MN-SC 
coculture model on the microfluidic biochips to recapitulate in vivo
conditions. MN is reportedly difficult to culture for more than a week. 
However, MNs were well-maintained in our coculture model for more 
than a mo. During this time, SCs not only supported the survival of 
motor neuron but also promoted the outgrowth of axons. This effect was 
found to arise from the SC-secreted progranulin (PGRN) and the
secretion of this protein was regulated by SC proliferation. We found that 
PGRN and their fragments, GRN C and GRN E, function as strong 
neurotrophic factors, enabling the viability of MNs for more than two 
weeks in MN culture without SCs. Furthermore, we found that the axon 
outgrowth could be promoted by optogenetic stimulation with a dramatic 
effect in MN monocultures. Furthermore, SC is a structurally important 
cell source, which forms myelin. We performed temporal quantitative
measurement of SC in the coculture model and found the effect of
coenzyme Q10 on the myelination promotion. These findings provide a 
very useful tool to enable us to break through the limitations in motor 
nervous system research. Our results might help to decipher the 
3myelination mechanism and learn more about MN diseases such as ALS,
through drug screening. Furthermore, this in vivo mimicking in vitro
model, might help in the study of post-injury mechanisms in greater 
detail by overcoming the limitations in the field of regeneration.
_____________________________________________________
Key Words: Motor neuron, Schwann cell, axon growth, myelination, 
progranulin, optogenetic stimulation, 3-dimensional microfluidic biochip
4Chapter I. 
Introduction
   1. Research Background
Myelin provides an electrically insulating material that forms a 
multilayered sheath around the axon of a neuron. In the peripheral 
nervous system (PNS), myelin sheath is generated by Schwann cells 
(SCs), whereas in the central nervous system (CNS), myelin is produced 
by oligodendrocytes (Fig. 1.1). The myelin sheath of axons formed by 
SCs and oligodendrocytes not only facilitates the conduction of action 
potentials in the nervous system, but also protects axons and provides 
nutritional support to the associated axons. Various defects in 
myelination, such as hypomyelination, delayed myelination, or 
demyelination, are known to cause debilitating neurological disorders.1-4
Hence, understanding how SCs and oligodendrocytes not only produce 
5myelin during developmental process and remyelinate axons during 
repair process of damaged neurons, is of enormous scientific interest. In 
many cases of nerve repair after physical injury, an incomplete
myelination of regenerated nerve fibers often results in malfunction of 
the repaired nerve.5
Figure 1.1. Schematic comparison of myelin formation in CNS and
PNS neurons. In the CNS, a single oligodendrocyte controls multiple 
neurons while in the PNS a single SC forms myelin around a part of a 
single neuron as glial cell.
6Several in vivo animal studies have been conducted to resolve the issue 
of limited neuronal repair process. The use of autologous6-8 or artificial 
nerve grafts9-11 has been reported to allow the repair of nerve defects 
when the injury gap is small or large. However, this repair process is 
associated with donor site morbidity as well as inadequate functional 
reinnervation causing inflammation. The reconstitution of the myelin 
sheath is eventually hard to achieve in such cases. 
Several in vitro models have also been developed. Methods to culture 
SCs and oligodendrocytes have been established and extensively applied 
to investigate the biology of myelinating glia.12-14 These cultures greatly 
improved the understanding of how SCs and oligodendrocytes 
differentiate and mature. In addition to culture systems comprising pure 
SCs or oligodendrocytes, a coculture system composed of both neurons 
and myelinating glia can provide insights into the interactions between 
myelinating glial cells and axons as well as the myelination process. 
Various coculture systems have been reported in literature, such as
coculture of oligodendrocytes and hippocampal neurons,14 SCs and 
sensory neurons (from dorsal root ganglia),12 and oligodendrocytes and 
retinal ganglion cells.15 Recently, Gingras et al.16 reported a method of 
culturing primary MNs on collagen-chitosan sponges seeded with 
fibroblasts or with a mixture of fibroblasts and SCs. While the coculture 
model of Gingras et al.16 enabled a long-term culture (lasting more than a 
7mo) of MN, the protocol required 21 days of a pre-culture for fibroblasts 
and/or SCs before the addition of MNs. They also reported that increased 
axon outgrowth could be achieved by several exogenous neurotrophic 
supplements, such as BDNF, neurotrophin-3, glial-derived neurotrophic 
factor, and ciliary neurotrophic factor. On the other hand, Haastert et al.17
reported that when cultured on a feeder layer of SCs, MNs survived in 
culture without supplementary support of neurotrophic factors for 20 
days in vitro (DIV), but the viability of MNs gradually reduced from 
more than 70% on DIV 3 to 12% by DIV 20. In addition, in the coculture 
model of MNs and SCs, mature MNs had enlarged somata but 
myelination of MN axons by SCs was not achieved during the culture 
period.
A few studies have used the in vitro culture method to recapitulate the 
nervous system on microfluidic biochips, based on microfabrication 
technologies.14,18-22 These techniques enable the development of 
elaborate devices to manipulate neurons and can be used to construct the
microscopic structure in biocompatible materials such as 
polydimethysiloxane (PDMS). Taylor et al.14 reported a method for 
culturing hippocampal neurons and oligodendrocytes using microfluidic 
platform, which enabled in vitro model that mimicked in vivo conditions 
for separating cell bodies and axon of neurons. These 2-D coculture 
8models provide insights into environment condition of neuron-glia 
interaction and myelin process, and eventually manipulation of these 
cells. Furthermore, Park et. al.21 reported a novel platform composed of
multi-compartment chambers, which enable isolation of axons from cell 
bodies and can be used for screening drugs as well as molecular factors 
that activate axon growth (Fig. 1.2). There is a substantial research 
interest in studying both physical interaction and molecular signals of 
neuron-glia during the development of nervous system to elucidate how 
to facilitate successful nerve repair after nerve damage as well as 
maintain healthy neurons through special stimulatory factor and/ or 
neurotrophic factors. 
9Figure 1.2. Microfluidic biochips to study development of nervous 
system. (A) The biochip induces axon growth of CNS neurons and 
isolates axons that were generated fluidically by volume difference 
between two chambers (images reproduced from Taylor et al. 2005). (B) 
The biochip consists of six axon-glia compartments that enabled carrying 
out multiple biomolecular treatment in 2-D neuron-glia coculture model 
(images reproduced from Park et al. 2012). 
Previous studies reported that axon growth and viability of neurons 
significantly increased when cultured with supplementary support of 
exogenous neurotrophic factors including brain-derived neurotrophic 
factor (BDNF),23 nerve growth factor (NGF),24 glia-derived neurotrophic
factor (GDNF),25 ciliary neurotrophic factor (CNTF).26 Furthermore, 
insulin–like growth factor-1 (IGF-1), functioning as a neurotrophic factor, 
10
enabled promotion of axon outgrowth of MNs27 and regulated the 
establishment of hippocampal neuronal polarity through the IGF-1 
receptor.28 Furthermore, these neurotrophic factors have a critical role in 
both neurodegenerative and metabolic diseases. 
In particular, recent studies investigated progranulin (PGRN), also 
known as proepithelin, granulin-epithelin precursor or PC cell-derived 
growth factor, composed of 7.5 granulins (Fig. 1.3, top panel), and is a 
key regulator in a subset of frontotemporal dementias (FTLD), which is 
one of the most common neurodegenerative disease resulting in behavior 
and/or speech changes.29,30 Pathogenic loss-of function of PGRN causes 
FTLD characterized by progressive deterioration of frontotemporal lobes 
and might induce susceptibility to metabolic disease.31 However, it is 
unclear how variation in PGRN causes these diverse diseases and more 
studies are required to clarify the mechanism that mediate PGRN 
function. PGRN is widely expressed in many cell types, including 
immune cells, adipocytes, epithelial cells, and neurons in the CNS and 
PNS, and participates in wound repair,32 inflammation to tumor growth,33
and neurodevelopment.29 In particular, PGRN plays a dual role in wound 
response wherein mRNA expression of PGRN was upregulated by 
specific cell types, including macrophages, neutrophils, enthothelia cells, 
and fibroblast after wounding, but diminished in intact skin. PGRN 
expression at injury site induces accumulation of immune cells, 
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fibroblast, and blood vessels to promote cell division, migration, and 
formulation of and tubule-like structure.32 Therefore, PGRN might play a
critical role in growth factor in wound healing.32 (Fig. 1.3, bottom panel)
Recently, PGRN has emerged as a novel angiogenic growth factor,
derived from human mesothelioma cells, which might promote cell 
proliferation and survival by activating proteins and induce VEGF-
independent angiogenesis.33 In addition, a few studies reported that 
PGRN enhances neurite outgrowth in cortical and hippocampal neurons31
as well as axon branching of hippocampal neurons,34 supporting the role 
of PGRN as a neurotrophic factor.35 Taken together, PGRN might play a
key role in repair process after injury, wherein PGRN expression is 
dramatically upregulated in immune cells and cleaved into granulins by
proteases as previously described.29,32
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Figure 1.3. Overview of PGRN structure and granulination process.
PGRN is composed of 7.5 highly homologous subunits known as 
granulins in top panel. At the injury site, PGRN is fragmented 
proteolytically into granulin peptides to promote division and migration 
of fibroblasts, enthothelial cells, and immune cells, while conversion of 
PGRN is inhibited by secreted leukocyte protease inhibitor (SLPI) at the
intact site.
Similarly, Al-Maied et al.36 and Brushart et al.37 used a powerful 
stimulatory factor, electrical stimulation, which enhances neurite 
spouting and growth after nerve injury. Peripheral nerve regeneration is 
known to be promoted by brief electrical stimulation of 20 Hz for 1 hr, 
followed by expression of regeneration-associated genes, including a1-
tubulin and GAP-43 (regeneration-associated genes; RAGs).36 In 
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particular, electrical stimulation enabled synchronization of 
reinnnervation and acceleration of regeneration into distal stump during 
nerve repair.37,38 Furthermore Demerens et al.39 reported electrical 
stimulation induced myelin process, followed by up-regulation of 
myelin-related gene transcription. While encouraging as a tool for 
promoting regeneration, electrical stimulation in regeneration of injured 
nerve still remains poorly understood due to limitation of cell-type 
specificity for precise exploration in electrophysiological mechanisms of 
injured nerve. 
Inspired by the effectiveness of electrical stimulation in nerve 
regeneration, optogenetic studies mentioned as a tool for neuroscience 
application, have been used, which allow precise target specificity in 
millisecond-timescale.40 Optogenetics, which includes the use of light 
source to control cells, especially neurons, that have been genetically 
encoded to express light-sensitive ion channels. Optogenetic activation 
of neurons in both in vivo and in vitro models has been used to control 
many aspects in the following regions; neural circuits in amygdala,41
mammalian behavior by regulating the activity of dopaminergic 
terminals,42 and in brainstem.43 Optogenetic activation accelerates fast 
light-activated channels and enzymes that allow temporally precise 
manipulation of biochemical and electrical proceeding by operating 
specific targeting mechanism. Furthermore Part et al.44 showed that 
14
optogenetic stimulation led to axon outgrowth of DRGs, which promoted 
expression of neurotrophic factors such as BDNF and NGF, and induced 
directional extension towards control DRGs, suggesting neurite 
chemotaxis. 
  
Figure 1.4. Schematic drawing summarizing the actions of axon 
growth by optogenetic stimulation.
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Here, we first report the use of optogenetics for promoting axon growth 
of MNs in MN monoculture. In our study, axon growth of MNs increased 
by using LED stimulation and more importantly, cAMP and PKA 
expression levels were also activated in light excitable MNs compared
with control (Fig. 1.4). Further, we investigated the utility of microfluidic 
biochips as a 3-D primary MN-SC coculture model; demonstrating its
ability to align SCs and MN axons separated from cell bodies of MNs. 
We biologically analyzed the axon growth and myelin process for gene 
expression in MN-SC developmental coculture. Notably, this coculture 
model in microfluidic biochip can be used as a method to screen 
compounds of interest for both axon generation and myelination. In 
particular, we applied to optogenetics only in MN regions to induce axon 
growth by using LED stimulation and treated with coenzyme Q10 to 
stimulate myelination as previously described (Fig. 1.5).45
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Figure 1.5. Overview of the dissertation. We established MN-SC 
coculture model for generation and myelination of axon from 2-D to 3-D
culture using microfluidic biochip. 
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2. Outline of Dissertation
In this dissertation, in vitro coculture models of motor neurons (MNs) 
and Schwann cells (SCs), which can promote both axon growth and 
myelination for a long-term (> 1 mo) were studied. The coculture models 
were based on 2-D and 3-D culture using traditional culture dish and/or a 
custom-built microfluidic biochip. The study was focused on evaluating 
the long-term viability of MN as well as myelination process of MN
axons as a result of the interactions between MN and SC. The study also 
included the effects of neurotrophic factors derived from SC and other 
exogenous stimulatory factors, such as chemical and electrical/optical 
stimuli, on MN viability and myelination.
The organization of this dissertation is as follows-Chapter I presents the 
theoretical background of the present study, and Chapter II the re-
establishment of MN-SC coculture model in 2-D. Chapter II is focused 
on culture methods, including the cell sources used to generate the 
peripheral motor nervous system and myelination process in vitro. In 
Chapter III, the potential effects of SC on the fate of MN are presented. 
In particular, progranulin (PGRN), a protein secreted by SC, is presented 
as a new neurotrophic factor to enhance the viability and axon growth of 
MN. In Chapter IV, the effectiveness of optogenetics as a tool to promote 
axon growth of MN at lower light intensity is described. Finally, Chapter
18
V discusses a 3-D MN-SC coculture model based on a custom-built 
microfluidic biochip. This device was used to closely 3-D environment 
of in vivo mimicking in vitro for axon growth and myelination of MN. In 
Chapter VI, the conclusions and future directions for this study are 
summarized at the end of the dissertation.
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Chapter II. 
2-D Coculture of Primary Motor Neuron 
and Schwann Cells 
1. Introduction
It is well known that primary culture of MNs alone can last only for 
several days in vitro because MNs are more vulnerable to oxidative 
stress than other types of neurons due to their high mitochondrial activity 
and metabolic activity.46  Several experimental methods have recently 
demonstrated that primary culture of MNs can maintain its viability by 
the presence of SCs in the culture.  Using a coculture model of MNs and 
SCs, Haastert et al.17 reported a long-term maturation of MNs up to 3 
weeks which enabled a formation of active synaptic network between 
MNs in vitro. Gingras et al.16 presented a 3-D tissue engineering model 
of MN-SC coculture using a collagen-chitosan sponge.  
In Chapter I, we report a coculture system comprising primary mouse 
MNs and SCs. In our system, MNs survived for at least 3 weeks in 
20
culture and more importantly, SCs differentiated and formed myelin 
sheath around the axons of MNs. In the coculture, neurons exhibited 
higher viability and extended longer axons as compared to MN 
monoculture. By employing standard cell biological and biochemical 
approaches, we have confirmed that SCs myelinate MN axons within 3 
weeks of coculture. The formation of myelin sheath was confirmed at the 
ultrastructural level. Furthermore, using the MN-SC coculture, we show 
that treatment with coenzyme Q10 facilitates myelination.45
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2. Materials and Methods
    A. Cell preparation
        (A) Schwann cell (SC) culture
All animal experiments were conducted in accordance with protocols 
approved by the Institutional Animal Care and Use Committee (IACUC) 
at the Korea Institute of Science and Technology. SCs were isolated from 
sciatic nerves of CD-1 mice at postnatal day 4 (P4), as previously 
described.12 Explants were incubated in Ca2+- and Mg2+-free phosphate-
buffered saline (PBS, Lonza) containing 0.05% trypsin (Sigma) and 0.05% 
collagenase A (Roche) for 30 min at 37ºC, followed by centrifugation at 
190 g for 5 min. The pellets containing tissue fragments and cells were 
then washed three times with high glucose-DMEM (Gibco) containing 
10% horse serum (HS) (Gibco). The harvested SC pellets were 
suspended in SC basic culture medium composed of high glucose-
DMEM, 10% HS, 4 mM L-glutamine (L-gln, Invitrogen), 100 units/mL 
penicillin/streptomycin (P/S, Sigma), 2 ng/mL human heregulin beta-1 
(Sigma), and 1~7 μM forskolin (Sigma)(Table 1). After suspension, SCs 
were seeded on 12 mmf coverslips at a density of 3x104 cells per 
coverslip. Prior to seeding SCs, the coverslips were coated with growth 
factor-reduced Matrigel (3 mm thickness on average). On DIV (days in 
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vitro) 4, complement-mediated cytolysis was performed to remove 
fibroblasts from SC culture. Briefly, the cells were lightly washed with 
20 mM HEPES (T&I) in Ca2+- and Mg2+-free HBSS solution 
(Invitrogen), followed by washing with HMEM (high-glucose DMEM 
containing 20 mM HEPES buffer, 10% HS, 4 mM L-gln, 100 units/mL 
P/S). After washing, 4 ng/mL anti-mouse CD90 (Serotec) in HMEM was 
added for 15 min at 37ºC, and 200 mL of rabbit human leucocyte-
associated antigens A, B, C (HLA-ABC) complement sera (Millipore) 
was added for 2 hrs at 37ºC. Cytolysis was terminated by washing cells 
with 20 mM HEPES buffer in HBSS (Table 3). After cytolysis, SCs were 
cultured for another three days in SC growth medium containing SC 
basic culture medium (described above) supplemented with 1~10 ng/mL 
of bFGF (Sigma) and 20 µg/mL of bovine pituitary extract (Sigma) to 
promote cell proliferation (Table 2). Purified SCs were characterized 
after complement-mediated cytolysis by confocal microscopy using 
GFAP, an intermediated filament protein found in non-myelinating SCs, 
and s100b, a marker of SCs (Fig. 2.1). Neither GFAP nor s100b was 
visible in fibroblasts.
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Table 1. Composition of SC basic medium
Component Concentration
DMEM           -
Horse serum       10%
      L-glutamine (200 mM)       1%
            Forskolin (5 mM)    1~7 µM
    Human heregulin beta-1   2 ng/mL 
Penicillin/Streptomycin           1%
                   
                 Table 2. Composition of SC growth medium
Component          Concentration
       Neurobasal medium          -
  Horse serum     10%
     L-glutamine (200 mM)      1%
         Forskolin (5 mM)   1~7 µM
   Fibroblast growth factor 1~10 ng/mL
Penicillin/Streptomycin    1%
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Table 3. Complement-mediated cytolysis
            Component            Concentration
Ca2+-, Mg2+-free 
Hank’s balanced salt 
solution
                          -
Anti-mouse CD90 anti-
Thy-1.2
    HEPES buffer
                   4 µg/mL
         5~20 mM
Rabbit Human 
leucocyte-associated 
antigens A, B, C            
    (HLA-ABC)
                    
                                             
           -
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Figure 2.1. Identification of purified SCs monoculture by confocal 
microscopy. Double immunocytochemistry for s100b (green) and GFAP 
(red) in SCs isolated from the sciatic nerves of postnatal (P) 4 mice.
(B) Motor neuron (MN) culture
MNs were harvested from the spinal cord of CD-1 mice (embryonic day 
14 [E14] fetus) as previously described47 with some modifications. 
Ventral horns of the spinal cord (L1-L6 segment) were collected in 
HBSS followed by incubation with 1% TLR trypsin (Worthington) for 15 
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min in a 37ºC water bath, and then treated with 1% TLR trypsin inhibitor 
(Sigma). To extract a purified population of MNs, cells dissociated from 
the explant were treated for 45 min at room temperature with a selective 
immuno-panning dish prepared with p75NTR antibody solution (1:5000, 
Abcam) in 10 mM Tris-HCl (pH 9.5, T&I). Suspensions, including nerve 
fragments and p75NTR-negative cells, were removed from panning dish 
by washing three times with pre-warmed neurobasal medium containing 
Glutamax 1 (Gibco). MNs bound to panning dish were then rinsed with 
depolarization solution (Table 5) containing 0.8% sodium chloride, 30 
mM potassium chloride, and 2 mM calcium chloride (Merck) in distilled 
water for 10 s, and gently collected in MN culture medium, composed of 
neurobasal medium (Invitrogen), 5~10% HS, Glutamax 1, B27 
supplement (Gibco), 1~10 μM β-mercaptoethanol (Sigma), and 5~20 
ng/mL BDNF (Gibco) (Table 4). MNs were collected by gentle pipetting, 
and were then centrifuged for 5 min at 190 g. After centrifugation, the 
pellets were re-suspended in MN culture medium. Purified MNs were 
stained with Tau protein, present in both dendrites and axons, and TuJ1, 
an axon marker of neurons (Fig. 2.1). 
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Table 4. Composition of MN medium
Component Concentration
Neurobasal medium -
Horse serum 5~10%
GlutamaxTM-1 (100X) 1%
Beta-mercaptoethanol  
(1M)
1~10 µM
Penicillin/Streptomycin
Brain-derived 
neurotrophic factor 
(BDNF)
1%
           5~20 ng/ml
Table 5. Depolarization solution
Component    Concentration(mM)
Potassium chloride 270~400
Sodium chloride 50~90
Calcium chloride 10~25
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Figure 2.2. Identification of purified MNs monoculture by confocal 
microscopy. Double immunocytochemistry for TuJ1 (green) and Tau 
(red) in MNs isolated from the ventral horns of spinal cord of embryos.
(C) MN-SC Coculture on Coverslips
MNs were plated (1x104 cells/coverslip) on top of a monolayer of SC 
culture, which was prepared as described above (Fig 2.3). MN were 
seeded on SC feeder layer on which SCs cultured on growth factor 
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reduced-Matrigel to faciliate both migration and wrapping process of 
SCs around axons. To induce myelination, MN-SCs were first cultured in 
a coculture growth medium for 7 days, after which 25~50 μg/mL of 
ascorbic acid (Sigma) was supplemented for subsequent culture (Table 6). 
For MN monoculture, MNs were cultured directly on Matrigel-coated 
coverslips without SC feeder layer (Fig 2.3A). For drug treatment, 
cultures were treated with coenzyme Q10 (Co-Q10, 1 µM) or riluzole 
(0.1 µM), as indicated. After 24 hours, samples were fixed and subjected 
to immunostaining with the indicated antibodies. Culture medium was 
replenished three times a week. 
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Table 6. Composition of MN-SC medium
Component Concentration
Neurobasal medium -
Horse serum 2~6%
GlutamaxTM-1 (100X) 1%
B27 supplement (10X) 1X
Brain-derived 
neurotrophic factor 
(BDNF)
10~50 ng/mL
Beta-mercaptoethanol 1~5 mM
Penicillin/Streptomycin 1%
L-ascorbic acid 20~50 ng/ml
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B. Measurement of cell viability
Live-Dead cell staining kit was used according to the manufacturer’s 
instructions (Abcam). Briefly, samples were labeled with mixture of 
solution A (Live-Dye) and solution B (propidium iodide, PI) in the 
staining buffer for 15 min at 37ºC. The samples were then washed once 
with the staining buffer and examined under Olympus IX71 with U-RFL-
T (detects FITC and TRITC). For NeuN immunostaining, cells were 
fixed with 4% paraformaldehyde (PFA) and treated with 0.2% Triton X-
100 (Sigma), followed by blocking in 4% BSA (Millipore) at 4ºC 
overnight. Cells were then labeled with NeuN antibody (1:500, Abcam) 
for 24 hrs at 4ºC, and were stained with Alexa Fluor 488 donkey anti-
mouse IgG (1:500, Invitrogen) for 1 hr at room temperature, followed by 
DAPI (Life Technologies) staining. The number of stained cells was 
counted from five random view-fields (Live-Dead cell staining and 
NeuN staining) of under the microscope. 
C. Immunocytochemistry
All samples were fixed with 4% paraformaldehyde (PFA) for 15 min at 
room temperature and washed twice with PBS. The fixed samples were 
then soaked in PBS containing 0.2% Triton X-100 (Sigma), followed by 
4% BSA (Millipore) at 4ºC overnight and labeled with the following 
primary antibodies: anti-Sox10 (1:500, Abcam), anti-s100β (1:500, 
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Abcam), anti-β-III Tubulin (TuJ1, 1:1000, Abcam), and anti-myelin basic 
protein (MBP, 1:500, Abcam). All samples with primary antibodies were 
incubated in 1% BSA with PBS at 4ºC overnight. The samples were then 
washed with PBS containing 1% BSA twice, and incubated with goat 
anti-chicken IgY H&L (1:1000, Abcam), goat anti-rabbit IgG H&L 
(1:500, Abcam), or Alexa Fluor 488 donkey anti-mouse IgG (1:500, 
Invitrogen). The nuclei of cells were stained with DAPI (Life 
Technologies) for 15 min at room temperature. Fluorescence of the 
culture was visualized under a confocal microscope (Zeiss LSM 700). 
D. Measurement of axon length
In Chapter II, cultures were fixed and labeled for TuJ1 to visualize axons
of MNs, and the lengths of axons were measured by using ImageJ 
software (100 axons/coverslip, N=3).
E. Quantitative analysis of pre-myelinating and myelinating 
Schwann cells
During 2-D coculture, cultures immunostained with anti-MBP antibodies 
showed two distinct patterns of MBP expression: pre-myelinating SCs 
showed relatively wide-spread expression of MBP adjacent to the axons 
while myelinating SCs showed highly localized expression of MBP 
along the axons. Cocultures were stained with MBP and TuJ1 at DIV 10, 
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14, and 21 and the proportion of these two types was calculated from six 
different fields of view under confocal microscope. 
F. Western blot assays
Expressions of MBP and Krox20 were quantitatively analyzed by using 
western blot analysis. The cells at DIV 1, 7, 14, and 21 were lysed in 
RIPA buffer containing 1% SDS and protease inhibitor (aprotinin, 
leupeptin, pepstatin A, PMSF). The protein concentration of cell lysates 
was measured by using Bradford assay. The samples were prepared in an 
SDS sample buffer, heated for 3 min at 98ºC, and 6 µg of the protein 
from each sample were loaded in SDS loading buffer and then 
transferred to a PVDF membrane. The membranes were blocked in 2.5% 
skim milk for 1 hr, followed by incubation with anti- rabbit Krox20 
(1:1000, Abcam) or anti-rat MBP (1:500, Abcam) antibodies at 4ºC 
overnight. The membranes were washed three times in TBST and 
incubated with goat anti-rabbit and anti-rat IgG conjugated with 
horseradish peroxidase (1:1000, Sigma) for 2 hrs. Bands were visualized 
by using the ECL system. The intensity of the blots was quantified with 
ImageJ software.
G. Transmission electron microscopy
At DIV 14 and 21, cultures were fixed with 4% glutaraldehyde in PBS 
and stored at 4°C overnight, and post-fixed with 1% osmium tetroxide 
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for 30 min. Samples were embedded in pre-epoxy resin before 
dehydration with a series of ethanol solutions (70%, 80%, 85%, 90%, 
95%, 100%). Sections were taken between 70~80 nm using 
Ultramicotome (Leica, Ultra Cut C) and picked up on copper grids, and 
stained in uranyl acetate and lead citrate. Images were acquired with 
Cryo-TEM (FEI, CryoTecnai F20). 
H. Statistical analysis
Average data were shown as mean ± standard error, and the comparison 
between different groups was performed by using repeated measures 
analysis of variance (ANOVA). Statistical significance was set at a value 
of *p < 0.05, **p < 0.01, ***p < 0.001.
35
3. Results
A. Establishment of a 2-D MN-SC coculture model 
To develop a long-term culture model of MNs, SCs were harvested from 
the sciatic nerves of postnatal day 4 (P4) mice and cultured on 
approximately 3 mm-thick Matrigel. SCs were cultured for a week until 
cells formed a confluent feeder layer. On top of SC feeder layer, purified 
MNs obtained from the ventral horns of gestation day 14 embryos (E14) 
were seeded and cocultured (Fig. 2.3B, MN-SC coculture). As a control, 
MNs were cultured directly on Matrigel without prior culture of SCs (Fig. 
2.3A, MN monoculture). In the MN monoculture, MNs extended axons 
up to DIV 7, but neurons gradually degenerated thereafter and by DIV 14, 
few MNs survived (Fig. 2.4). By contrast, in the MN-SC coculture, 
neurons differentiated and developed neurites and remained intact up to 
at least DIV 21. On DIV 3, we detected the migration of SCs toward the 
axons of MNs and on DIV 7, and observed nuclei of SCs around the 
axons. 
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Figure 2.3. Schematic illustration of MN monoculture and MN-SC 
coculture on a Matrigel. (A) MNs cultured on a coverslip coated with 
growth factor-reduced Matrigel. (B) MNs cultured on a SC feeder layer 
that grew up to 90% confluency.
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Figure 2.4. Flowchart of differentiation of MNs in culture. 
Representative light microscopic images of MN monoculture and 
MN-SC coculture at different stages are shown. In MN monoculture, 
purified neurons form synapses at DIV 7, but viability greatly reduces by 
DIV 14. In MN-SCs coculture, SCs are cultured for 7 days, and then 
MNs were grown on top of the SC feeder layer. MNs in the coculture 
survive for at least 3 weeks and motor axon diameter increases (arrows, 
yellow). All images are at the same scale. Scale bar, 50 µm.
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B. MN cell viability in both monoculture and coculture
We also compared cell viability in MN monoculture and MN-SC 
coculture systems by using Live-Dead cell staining kit and NeuN-DAPI 
double staining methods (details in Methods section). In the MN 
monoculture, vast majority of neurons (96%) failed to survive (Figs. 
2.5A and B). However, the MN-SC coculture showed almost no cell 
death up to DIV 21 (Fig. 2.5C). Furthermore, the viable MN cell number 
was maintained throughout the culture, whereas the viable SC cell 
number steadily increased up to DIV 21 (Fig. 2.5D), suggesting that SCs 
play a critical role in supporting the survival of MNs.
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Figure 2.5. Cell viability in MN monoculture (A and B) and MN-SC 
coculture (C and D). Viability was assessed by double-staining with 
calcein-AM and propidium iodide (PI) at DIV 0, 7, 14, or 21, as 
indicated (A and C). Samples were then fixed and immunostained with 
DAPI and NeuN antibody (B and D). Representative images (A and C) 
and quantification of NeuN-positive MNs are shown (B and D). n=5;
scale bar, 100 µm.
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C. Axon length of MNs in monoculture and coculture
We next quantitatively examined the effects of SCs on axon outgrowth 
of MNs using TuJ1 staining for nerve fibers, and ImageJ to quantify the 
fiber length (Fig. 2.6). When axon length was measured at 2 days after 
plating MNs (Fig. 2.6A), average axon length of MNs grown in the MN-
SC coculture system was about 4 times longer than that in the MN 
monoculture. In the MN-SC coculture, axons grew at a rate of about 50 
mm per day, which is consistent with a previous report.13 Taken together, 
these results suggest that SCs are essential for the survival and neurite 
outgrowth of MNs.
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Figure 2.6. Axonal outgrowth in MN monoculture and MN-SC 
coculture. (A) Confocal images of MN monoculture and MN-SC coculture 
are shown. Cells were fixed and stained for s100β, TuJ1 and nucleus 
(DAPI), as indicated, at DIV 2, and lengths of axons were measured. Scale 
bar, 50 µm. (B) Each bar represents mean ± S.E. value. n=100; *** p < 
0.001.
D. Myelination of MNs
To investigate if SCs differentiate and, more importantly, myelinate MN 
axons in our MN-SC coculture system, cultures were examined for 
expression of markers of SC differentiation and myelination, such as 
myelin basic protein (MBP), SRY-related HMGbox-10 (Sox10) and 
Krox20. We found that the expression of Sox10, a transcription factor 
which controls myelination in the PNS,48 was detected in the soma of 
SCs on DIV 7 and increased thereafter (Fig. 2.7). Expression of MBP 
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was detected on DIV 10, and eventually became highly localized along 
the axon fiber by DIV 14 (Fig. 2.7, green). Western blot analysis 
confirmed the expression of MBP and Krox20, a transcription factor 
induced by the activation of Sox10. Krox20 is known to suppress the 
immature state and promote myelination.49,50 We observed an increase of 
both MBP and Krox20 protein levels over time (Fig. 2.8), consistent with 
our immunocytochemistry results (Fig. 2.7).
Next, we examined myelin sheath formation on DIV 21 in detail by 
confocal microscopy and transmission electron microscopy (TEM). Z-
stack images of confocal microscopy confirmed tight interaction between 
MBP and axons of MNs (Fig. 2.9). By taking TEM images, we 
confirmed that SCs formed loose sheaths by DIV 14, which could be the 
premyelination stage (Figs. 2.10A and B), and that SCs tightly wrapped 
the nerve fiber by DIV 21, which could be the completed myelination 
stage (Figs. 2.10C and D). The thickness of compact myelin sheaths was 
approximately 0.2 µm at DIV 21.
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Figure 2.7. Differentiation of neurons and SCs in MN-SC coculture.
Representative confocal images of MN-SC coculture are shown. Cells were 
fixed and stained for Sox10, MBP, TuJ1 and nucleus (DAPI) at DIV 7, 10, and 
14, as indicated. Note the expression of MBP protein around axons at DIV 10 
and 14. Scale bar, 50 µm.
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Figure 2.8. Increased expression of Krox20 and MBP protein in MN-
SCs coculture. The levels of Krox20 and MBP were determined by 
western blot analysis at DIV 1, 7, 14, and 21, as indicated. 
Representative blots (A) and quantification (B) of Krox20 and MBP 
levels are shown.
Figure 2.9. Formation of compact myelin sheaths in the MN-SCs 
coculture model. At DIV 21, cultured cells were observed by confocal 
microscopy after immunolabeling with anti-MBP (1:500, green) and anti-
TuJ1 antibodies (1:1000, red). Images shown at the top and bottom 
panels are serial images collected throughout z-sections. Scale bar, 5 μm.
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Figure 2.10. Myelination of axons in the MN-SC coculture model. 
The extent of myelin sheaths was analyzed by transmission electron 
microscopy at DIV 14 and 21. Micrographs from DIV 14 show SCs 
loosely wrapping around the nerve fiber (A, B), whereas those from DIV 
21 clearly show the formation of compact myelin sheaths (C). (D) 
Representative image shows a heavily myelinated nerve fiber. Scale bar, 
200 nm (A-C), 20 nm (D). N, nerve fiber; m, myelin sheaths.
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E. Distinct stages of myelination observed in the 2-D MN-SC 
coculture model
It is well-known that oligodendrocytes in the CNS differentiate from 
premyelinating to myelinating stage, and the transition is controlled by 
several intrinsic and extrinsic signals.51 Likewise, in our MN-SC 
coculture system, SC myelination proceeded through two distinct stages, 
which could be distinguished on the basis of MBP expression pattern and 
interaction with axons as mentioned above in the TEM images. In the 
premyelinating stage, expression of MBP in SCs was relatively 
widespread, whereas in the myelinating stage, MBP expression in SCs 
was tightly localized along the axons. By counting the number of these 
two different types of SCs under confocal microscope, we found that 
while most SCs were at pre-myelinating stage on DIV 10. The number of 
myelinating SCs gradually increased in culture and reached 80% by DIV 
21 (Fig. 2.11B).
47
Figure 2.11. Pre-myelinating and myelinating SCs. (A) The process of 
myelination. SCs envelop an axon and continue to produce myelin. SCs 
then wrap their plasma membrane loosely around an axon, yielding in 
multiple successive layers. Membrane wrappings are compacted into a 
tightly packed insulation coat. (B) SCs in culture were fixed and stained 
for MBP at DIV 10, 14, and 21, as indicated. MBP-expressing SCs were 
categorized into two groups, pre-myelinating and myelinating (n=5).
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F. Promotion of MN myelination by coenzyme Q10
We next treated our coculture samples with drugs implicated in the 
treatment of neurological diseases. Samples were treated with riluzole (2-
amino-6-trifluoromethoxy benzothiazole), an FDA-approved drug for the 
treatment of amyotrophic lateral sclerosis (ALS),52 a debilitating 
neuromuscular disease which involves the death of motor neurons; or 
with coenzyme Q10 (Co-Q10) (1,4-benzoquinone, also known as 
ubiquinone), an antioxidant and mitochondrial cofactor, which has been 
considered as a potential therapeutic agent for demyelinating and 
neurodegenerative diseases.53,54 As shown in Figs. 2.12A and B, Co-Q10 
treatment facilitated MBP expression and increased the number of 
myelin-forming SCs as compared to control. At DIV 7, MBP expression 
was detected only in Co-Q10-treated cultures but not in control or 
riluzole-treated cultures. By DIV 14, MBP expression was also detected 
in control and riluzole-treated cultures, but the percentage of myelinating 
SCs was lower as compared to Co-Q10-treated cultures. By DIV 21, all 
cultures expressed MBP. We detected an increase of Krox20 expression
in all cultures, demonstrating that SCs differentiate properly in our MN-
SC coculture system, and that treatment of riluzole or Co-Q10 did not 
affect the transition from premyelinating to myelinating stage per se but 
perhaps controls later stages of SC myelination (Fig. 2.12C).
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Figure 2.12. Effects of drug treatment on myelination. Comparison of 
MBP expression in MN-SC coculture treated with coenzyme Q10 (Co-
Q10) or riluzole using immunocytochemistry. Note the marked elevation 
of pre-myelination in cultures treated with Co-Q10 at DIV 7. n=5; *p < 
0.05; scale bar, 20 μm.
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Chapter III. 
Progranulin (PGRN), A Novel SC-
Secreting Protein: Effects on Viability and 
Axon Growth of Motor Neuron.
1. Introduction
Many studies25,55 have reported that SCs produce a wide variety of 
neurotrophic factors, which are critical for the viability and myelination 
of peripheral neurons as well as for their repair after injury. For example, 
Henderson et al.56 reported that glial cell line-derived neurotrophic factor
(GDNF) produced by SCs is an important survival factor for MNs in 
culture.  Later, it was reported that when sciatic nerve was subjected to a
chronic injury, GDNF mRNA was rapidly upregulated in SCs around the 
injury site.57 SC is also known as a rich source of brain-derived 
neurotrophic factor (BDNF), nerve growth factor (NGF), and ciliary 
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neurotrophic factor (CNTF).26 BDNF promotes nerve regeneration by 
enhancing axon branching and arborization of neuron27 and also by 
upregulating IL-6 expression by SCs.58  CNTF was proven not only to 
support viability of MN but to prevent degeneration of MN after injury.59
Recent studies reported progranulin (PGRN) as a potential 
neuroprotective growth factor to support the survival of MN35 and also as 
a potent regulator of neuronal differentiation and outgrowth.34
In Chapter III, using a transwell culture model of MN and SC, we 
examined the role of progranulin (PGRN) as a potential neurotrophic
factor to promote the cellular viability and axon growth for MNs.
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2. Materials and Methods
A. MN-SC coculture on transwells
Viability of MNs controlled by SC-secreted proteins was analyzed by 
using transwells. Transwells were pre-coated poly-l-lysine (PLL)
solution for 3 hrs at 37˚C, and then initially equilibrated by adding 
culture medium for at least 1 hr before SC seeding in the upper transwell 
inserts (1.5 x 104 cells/transwell insert). One day after SCs seeding, 
coverslips seeded with MNs (1 x 104 cells) were placed onto the lower 6 
wells. Coculture medium composed of neurobasal medium with 2~10% 
HS, 2 mM L-Gln, 1X B27 supplement, 10 µg/mL BDNF, 5 µM forskolin 
and 1 mg/mL pituitary extract bovine. To test the viability of MNs on 
transwell coculture, we were treated it with SLPI (100 nM, PROSPEC, 
USA) on coculture medium. The co culture medium was changed three 
times a week.
B. Mass spectrometric assays
Identification of protein was performed by in-gel digestion using PGRN-
containing gel pieces cut from SDS-PAGE gels. The procedure followed 
as previously described.60 The tryptic peptide was analyzed using a LTQ 
XL-Orbitrap mass spectrometer (Thermo Scientific, San Jose, CA, USA) 
coupled with an Eksigent nanoLC-ultra 1D plus system at a flow rate of 
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300 nL/min, with a linear gradient of acetonitrile from 5% to 40% in 
water in the presence of 0.1% formic acid over a period of 40 min. The 
spray voltage was set to 1.9 kV, and the temperature of the heated 
capillary was set to 250°C. The instrument cycled through acquisition of 
a full scan (m/z 300–2,000) followed by 10 data-dependent MS/MS 
scans coupled with a predefined inclusion list including the m/z values of 
proteotypic peptides for PGRN (isolation width, 2 m/z; normalized 
collision energy, 27%; dynamic exclusion duration, 30 s). The acquired 
MS/MS spectra were searched against composite Uniprot mouse (Jan 
2015 release) with horse albumin and NCBI mouse PGRN sequence 
database using SEQUEST in Proteome Discoverer 1.4 (Thermo Fisher 
Scientificion, version 1.4.0.288).61 Two trypsin-missed cleavages were 
allowed and the peptide mass tolerances for MS/MS and MS were set to 
±0.5 and ±15 ppm, respectively. Other options used for SEQUEST 
searches were fixed modification of carbamidomethylation at cysteine (+ 
57.0215 Da), variable modifications of oxidation at methionine (+ 
15.9949 Da).
C. Gene transfection
To measure axon growth dependent on PGRN concentration and SLPI 
concentration, at DIV 4 after seeding, MNs were transfected with 
tdTomato (1 µg/coverslip) for 1 hr in 37˚C incubator using CalPhos 
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mammalian kit (Clontech Laboratories, Inc.) as previously described62
with some modifications. Briefly, the mixture of 1 µg/mL DNA in 
culture medium containing 0.04 M CaCl2 and 2X HBSS solution were 
incubated for 30 min at room temperature. The DNA/Ca2+-phosphate 
suspension was added on MNs that were cultured on coverslips and 
incubated for 90 min at 37°C incubator. After incubation, DNA/Ca2+-
phosphate precipitates were removed by adding new MN culture medium 
that was pre-equilibriated in 10% CO2 incubator for at least 30 min. 
D. Measurement of axon length
In chapter III, tdTomato-transfected MNs were labeled for TuJ1 to 
measure co-labeled axons and measured by using ImageJ software (10 
axons/coverslip, N=5).
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3. Results
A. MN viability on transwell coculture model
We initially examined whether the viability of MNs were controlled by 
SC-secreting protein or not. We cocultured primary SCs grown in the 
upper chamber of transwell inserts with MNs cultured on coverslips in 
the lower chamber of transwell insert (Fig. 3.1A). As previously 
reported,45 we found that neurotrophic factors released by SCs also 
promote the viability of MNs compared with MN monoculture, using 
live and dead staining kit (Figs. 3.1B and C). However, the viability of 
MN cultured on transwell was lower than that of MNs cultured on SC 
feeder layer (Figs. 3.1C and D). Furthermore, we observed that these 
effects attenuated to about 46% by addition of SLPI (100 nM) on DIV 14 
(Figs. 3.1B and C). These results suggest that neurotrophic protein 
released by SCs is critical to maintain the viability of MNs, and this
viability effect can be abolished by SLPI.
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Figure 3.1. Cell viability was compared between MN monoculture 
and MN-SC coculture using transwell. (A) Diagram of transwell 
coculture. MNs in lower compartment that cultured on coverslips pre-
coated with PORN and laminin, whereas SCs in upper compartment 
were plated on PLL pre-coated membrane. (B) The cultures were double-
stained with calcein-AM and propidium iodide (PI) at DIV 7 and 14 to 
evaluate cell viability. (C and D) Viability of MNs was quantified by 
counting the number of live (stained in green) and dead (stained in red) 
cells under fluorescence microscope. Each bar represents mean ± S.E. 
value. (n=3, 5 random regions), ***p < 0.001, Scale bar, 50 µm.
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B. Identification of PGRN secreted by SCs
We next examined whether PGRN is secreted from SC or not. To identify 
PGRN in media, primary SC were cultured in medium supplemented 
with 10% HS for 72 hrs to stabilize cells after seeding, and then culture 
medium was serially diluted into serum-free condition (Fig. 3.2A). 
Through LC-MS/MS, PGRN were identified from 4 peptide sequences 
(HCCPGGFHCSAR, VHCCPHGASCDLVHTR, AVSLPFSVVCPDAK,
and LPDPQILK) in conditioned medium without serum (Fig. 3.2B). 
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Figure 3.2. Identification of PGRN secretion in SCs conditioned 
medium using Liquid Chromatography-Tandem Mass Spectrometry.
(A) Flowchart of cell culture to harvest of the supernatant derived from 
SCs. The medium was changed and diluted in half with serum-free 
medium serially (every two days after DIV 3). (B) PGRN was identified
with 4 peptides in serum-free media (FDR < 1%).
C. Regulation of PGRN secretion by SC culture conditions
To investigate if PGRN expression level were controlled by SC culture 
conditions such as dependency on time and serum concentration, we 
examined expression levels of PGRN as well as markers of SC 
differentiation, such as Krox 20. 
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- Day-dependent conditions
We first examined PGRN expression levels during SC proliferation. To 
quantify PGRN levels, we seeded SCs at different densities on culture 
dishes to acquire the same number of cells when SCs were harvested on 
DIV 1, 3, 7, and 14. Half of the culture medium was exchanged every 
two days, and SCs were incubated with fresh medium for 1 day before 
obtaining samples (Fig. 3.3A). We observed an increase in the PGRN 
and Krox20 protein levels over time using western blot analysis, and the 
average PGRN and Krox20 expression levels were 1.5 and 3.13-fold
higher than that of DIV 1, respectively (Fig. 3.3B).
- Serum levels
We next examined the PGRN protein level under different serum 
concentration in SC culture medium. To acquire each culture samples, 
SC culture media were diluted by exchanging 50% serum-free medium 
every day at DIV 3 after stabilization of SCs. At DIV 6, SCs were 
washed with PBS once and the medium in each condition was exchanged 
before cell lysates were harvested (Fig. 3.4A). We found that PGRN 
protein level was higher in 10% horse serum condition than in 0% horse 
serum condition. Furthermore, we confirmed that Krox20 expression 
levels were also increased with horse serum condition (Fig. 3.4B). These 
results demonstrated that PGRN expression was increased under SC 
serum culture condition, with a concurrent increase in Krox20 expression.
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Figure 3.3. Increase in PGRN secretion by day-dependent SCs. (A) 
Schematic procedure of preparation of cell lysates at day 1, 3, 7 and 14 to 
analyze protein levels of PGRN and Krox20. (B) Representative blots 
(left) and quantification results (right) are shown. Each bar represents 
mean ± S.E. value. n=5, 10 axons/ each group; *p < 0.05, **p < 0.01,
*** p < 0.001.
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Figure 3.4. Increased expression of PGRN by serum levels-
dependent SCs. (A) Schematic procedure of preparation of SCs lysates 
from SCs cultured in different serum levels (10%, 5%, 2.5%, 1.25% and 
0% serum) at DIV 7 to analyze protein levels of PGRN and Krox20 (C).
Each bar represents mean ± S.E. value. n=5; *p < 0.05, **p < 0.01, *** 
p < 0.001.
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D. Exogenous PGRN enhances viability and axon growth of 
MNs
To explore the neurotrophic properties of PGRN, we evaluated whether
axon growth of MNs was regulated by PGRN in a dose-dependent 
manner. We used tdTomato transfection using calcium phosphate 
methods at DIV 5, which enabled us analyze precisely a single axon of 
MN. At DIV 6, fixed MNs were immunostained with TuJ1 and 
tdTomato-TuJ1 stained axons were counted using ImageJ (Fig. 3.5A) We 
identified that axon growth improved significantly with treatment of
recombinant PGRN ranging from 0.01 nM to 10 nM in MN monoculture 
at DIV 6, wherein rPGRN was added on day 0 in cultures (Fig. 3.5B, top 
panel). The elongation of axons was about 1.5- fold more in 1 nM 
rPGRN (236.973 ± 24 µm) condition, compared to control (144.483 ±
10 µm). We did not observe a significant increase when rPGRN 
concentration was above 1 nM (Fig. 3.5C, left panel). Furthermore, these 
neurotrophic effects of rPGRN were attenuated by adding rSLPI at 
different concentrations. Treatment of rSLPI on growth-promoting 
effects of rPGRN have decreased axon length of MN with increasing
SLPI concentration, especially, MNs treated with 10 nM SLPI (129.096 
µm) that have short axon length similar to that of control MNs (144.486 
µm) (Fig. 3.5B, bottom panel, and 5C, right panel).
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Figure 3.5. Axon growth of MN was dependent on the concentrations 
of PGRN and SLPI, a molecule that deactivates PGRN by blocking 
the hydrolysis of the protein. (A) tdTomato gene was transfected in
MNs using DNA-calcium phosphate method to visually identify the axon 
outgrowth. (B) Representative images of tdTomato-MNs demonstrating 
axon growth as a function of PGRN and SLPI concentrations. (C) Axon 
length of MNs shown in (B) was measured using ImageJ software. Note 
that axon length of MN increased with an increase in PGRN 
concentration, but decreased with an increase in SLPI concentration.
Each bar represents mean ± S.E. value. n=5, 10 axons/ each group; *p <
0.05, **p < 0.01, *** p < 0.001. Scale bar, 50 µm.
E. Effects of PGRN fragments on MNs
We next sought to determine which PGRN fragment promoted viability 
and axon growth of MN. Previous studies in MN monoculture have 
suggested that MNs did not survived after DIV 14 without SC.16,45
However, we found that exogenous PGRN treatment promoted MNs 
viability (62%) at DIV14 in MN monoculture compared with that of 
control. In particular, both GRN C (72%) and GRN E (74%) significantly 
improved MNs viability at DIV14, confirming that GRN C and GRN E 
of PGRN fragment have neurotrophic properties (Fig. 3.6A and B).  
Zhu et al.63 reported that SLPI blocked PGRN processing by direct 
binding to PGRN and by inhibition of elastase-mediated digestion that 
converts PGRN to PGRN fragments during wound healing. We therefore 
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examined the effect of SLPI on both PGRN and PGRN fragments and 
observed that co-administration of SLPI prevented the neurotrophic 
properties of PGRN in MN monoculture at DIV 14. However, we found 
that SLPI interacts with PGRN but not PGRN fragments. When we 
added SLPI in the GRN C and GRN E conditions, SLPI did not affect the 
neurotrophic ability of PGRN (Fig. 3.6C and D).  
Previous experiments showed that neurite outgrowth increased after
GRN C as well as GRN E treatment, and the increase in axon length and 
soma size was less than that by PGRN31. However, in contrast, we found 
that GRN C and E have an effect on axon growth extension than that by
PGRN (Fig. 3.7A). Axon growth of MNs treated with GRN E 
significantly increased (341.24 ± 32 µm) and was about 2.2 times longer 
than that of control (Fig. 3.7B).
Our results demonstrate that PGRN were secreted from SC, which is a 
neurotrophic factor that enhances viability and axon growth of MNs. 
Interestingly, the viability of MNs decreased significantly at DIV 7 after 
culture as previously described. However, the PGRN fragments, GRN C 
and GRN E, were able to maintain the viability of MNs at DIV14.  
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Figure 3.6. Protection of PGRN fragments against MNs’ cell death.
Representative images (A) and quantification (B) from calcein AM- PI 
stained MNs that were treated with PGRN, GRN C, GRN E (200
ng/mL/each protein) are shown for indicated time.
Figure 3.7. Promotion of axon growth of MNs by PGRN fragments.
Representative images (A) and quantification results (B) of axon growth 
are shown.
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Chapter IV.
Optogenetic Stimulation of Axon Growth 
of Motor Neuron.
1. Introduction
External stimulation has been known to have an effect on the survival 
and the growth of the neuron.31,44,64 Among them, electrical stimulation 
(ES) has long been considered as a potential tool to stimulate axon 
regeneration of neurons in central and peripheral nervous systems.65,66
When electrically stimulated with a low frequency DC pulse train for 1 
hour, the axon regeneration of transected femoral nerve was greatly 
enhanced,67 and it was mediated by the upregulation of BDNF and its 
receptor trkB.36 It was also reported that a brief, low-frequency ES of 
transected sciatic nerve accelerated axon regeneration as well as 
myelination inside a silicon-rubber conduit interposed between two 
transected nerve stumps in animal model.68 When cultured with SC in 
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vitro, on the other hand, the myelination of dorsal root ganglion (DRG) 
cells was reduced by ES with as low frequency as 0.1 Hz.69 A recent in 
vitro model by Koppes et al.70 demonstrated 7-fold increase of axon 
outgrowth by ES on DRG neurons encapsulated within carbon nanotubes 
(CNT)-collagen composite hydrogel. While presenting as a potential 
means to enhance neurite outgrowth and myelination for peripheral 
nerves, ES lacks a cell-type specificity, thus impeding the specific 
analysis of the underlying mechanism in particular for neuron-glia cell 
coculture models.
In Chapter IV, we introduce optogenetics as a stimulatory factor to 
promote axon growth in MN monoculture. Additionally, we investigate 
optically excitable MNs at low intensity, which can induce optical 
upregulation of proteins that is typically generated by signaling 
cascades.71
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2. Material and Methods
A. Gene amplification and transfection
- Gene amplification
CatCh: ChR2(L132C)-YFP; vector: pAAV-CMV which has L132C 
mutation of humanized channelrhodopsin2 (ChR2) with H134R mutation 
fused EYFP was obtained from Addgene (Addgene Inc., USA) (Fig. 
4.1).72 To amplify pCatCh, plasmid was transformed into DH5∂ 
competent E. coli cells that is useful for recombinant DNA methods as it 
enables insert stability and promotes the quality of DNA purified from 
minipreps. Transformed bacterial cells were then cultured in LB medium 
(Sigma) containing ampicillin (1 mg/mL, 1:1000, Sigma) and incubated 
at 37°C for 18 hours. Bacterial pellet that harvested by spinning at 13000 
rpm for 1 min, were resuspended in 250 µL resuspension solution 
containing RNaseA before cells were lysed in lysis buffer (400 mM 
NaOH and 2% SDS) and mixed gently by inverting 3 times. Lysed cells 
were then treated with neutralization buffer (5 M potassium acetate, pH 
5.5) and centrifuged for 15 min to precipitate debris consists of bacterial 
DNA and protein. Cleared supernatants were transferred to a column 
carefully and centrifuged for 1 min at 13000 rpm. After washing the 
column twice with wash buffer containing 70% ethanol, distilled water 
(DW) was added in the column for elution of DNA.
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- Lipofectamine method
To transfect MN with pCatCh-EYFP (Addgene) in MN regions of the 
device, the mixture of DNA (5 µg)-lipofectamine 2000 (Invitrogen) in 
serum-free MN medium was incubated for 30 min at room temperature. 
After incubation, DNA/ lipofectamine suspension was added in the MN 
chamber at DIV 2 for 1 day at 37°C incubator. The medium in the MN 
chamber was then changed with MN culture medium.71  
   
Figure 4.1. Gene map of pAAV-CMV-CatCh-EYFP. CatCh was constructed 
by L132C mutagenesis of humanized channelrhodopsin2 (ChR2) with H134R 
mutation fused EYFP (image reproduced by Dr. Eun Mi Hwang of Center for 
Functional Connectomes of Korea Institute of Science and Technology(KIST), 
Seoul, Korea).
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B. Measurement of axon length
In Chapter IV, TuJ1-labeled MN in each group (control on/off) and both 
GFP and TuJ1 co-labeled MN in each group (Transfection on/off) were 
measured using ImageJ and quantified (50 axons/each group, N=5).
C. LED stimulation array
To transmit pulsed blue light to transfected MN, 24 blue light-emitting 
diodes were customized and modified as previously described (Fig.4.2).44
Briefly, LEDs (473 nm wavelength) that were covered with 45 or 90 
degrees lens (Eleparts) for uniformly illuminate to the target cells, and 
filtered out UV wavelength from UV protector film, were driven by 
power supply, DP832 series (Rigol technologies). The intensity of LEDs 
was yielded uniformly at an irradiance of 1 mW/mm2 and delivered to 
optically-sensitive MN, as measured by an optical power and energy 
meter (Thorlabs). The duration of the light pulse was set to1 s, and the 
interval was set to 9 s.71
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Figure 4.2. The schematic depiction of a custom LED array for 
optical stimulation.
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D. ELISA analysis
The intracellular concentrations of cAMP and PKA in MN were 
measured using cAMP (Cayman Chemical, USA) and PKA kinase 
activity kit (Abcam, UK) according to the manufacturer’s instructions. 
After 0, 1, 24, 48 hrs of optical stimulation, the cells were lysed in RIPA 
buffer (T&I) containing protease inhibitors Cocktail (Sigma) and 
centrifuged to remove cell debris for 5 min at 4˚C.  After the total protein 
content of the cell lysate was measured by Bradford assay, the samples 
were loaded onto the ELISA plates.  The samples for cAMP analysis 
needed to be acetylated to amplify the signal level before being loaded 
onto the plate.  The optical absorbances for cAMP and PKA were 
measured using microplate reader (Thermo) at 450 nm, and were 
quantitated against the respective standard curves.
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3. Results
A. Gene transfection using lipofectamine and transfection 
efficiency
We used a special ChR2 variant to excite cells at lower intensity. 
Kleinlogel et al.72 reported a new ChR2 variant; CatCh that is an ultra 
light-sensitive Ca2+ permeable ChR2 variant than that of wild- type ChR2 
allowing accelerated response time, and is expressed on the membrane, 
not in cytosol. We measured the transfection efficiency of MNs after 
transfection of pCatCh using lipofectamine reagents (Fig. 4.3A) and 
quantified the transfection efficiency as the ratio of counted MN, which 
co-labeled with GFP and DAPI, over MNs stained DAPI only (Fig. 4.3B). 
We confirmed that about 75%~80% cell bodies were co-immunostained 
GFP and DAPI, compared to MNs stained DAPI only (Fig 4.3B).
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Figure 4.3. CatCh-expression in MNs. (A) Schematic procedure of 
preparation of MNs that were transfected with pCatCh using 
lipofectamine reagent at DIV 2, and efficiency of pCatCh transfection 
was analyzed by immunocytochemistry at DIV 4. (B) Representative 
images (left panel) and quantitative results (right panel) are shown. Scale 
bar, 100 µm; n=3, three random regions.
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B. Phototoxicity and MN viability
MNs are more sensitive than other peripheral neurons such as DRGs that
isolated from transgenic mouse expressing ChR2 can be optically 
sensitized at 5~6 mW intensity using optical stimulation.44 However, 
MNs is not. MN monocultures are very difficult to maintain for a long 
time17, 45, 75, 76 and are susceptible to external environment such as light, 
temperature and CO2 conditions. We next assessed the MNs viability 
under different light intensity (1 mW~ 8 mW/mm2) at DIV 4, and 
measured it by using calcein-AM and PI assays kit at DIV 5 (Fig. 4.4A). 
We identified that MN steadily survived under light stimulation 
compared to non-stimulated MNs (Fig. 4.4B). The MN viability was 
quantified as shown in Figure 4.4C. MN viability was maintained at 3 
mW or less intensity and was significantly decreased at 5 mW of more 
intensity. However, MN viability (73%) at 3 mW intensity was slightly 
reduced compared to non-stimulated MNs, and the ratio of MN viability 
at DIV 7, was similar to a previous report.45 Lower light intensity (1
mW/mm2) was chosen to excite MN, consistent with the threshold for 
ChR2- facilitated neural excitation. No significant difference between 
control and 0 mW was observed.
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Figure 4.4. Cell viability by optical stimulation at different intensities.
(A) Temporal schematic of optogenetic stimulation of 2-D MN culture. 
The inlet shows the blue light-stimulation protocol of ON for 1 s and 
OFF for 9 s, repeated ten times over the period of 100 s. (B) Viability of
transfected MN by optogenetic stimulation was measured by double-
staining with calcein-AM and propidium iodide (PI) at 0, 1, 4, 5, 8 mW 
intensities, as indicated (n=3). Scale bar, 100 µm.
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C. Axon growth by optogenetic stimulation
We next asked if axon growth of MN was also influenced by optical 
stimulation as a means to promote axon length of other neurons as 
previously described.44
To investigate the effect of optical stimulation on axon growth of 
transfected MNs, we examined optically stimulated CatCh-MNs, as 
compared to unstimulated CatCh-MNs, stimulated WT-MNs, and 
unstimulated WT-MNs (Fig. 4.5B). The optical stimulation was 
conducted using custom-built setup designed to provide uniform 
stimulation 10 cycles of 1 s ON and 9 s OFF. MNs were stimulated three 
times every 30 min (473 nm wavelength, 1 mW/mm2). Consistent with 
previous works,44,71 axon growth of optically sensitive CatCh-MNs 
significantly increased by 2.5 fold than other groups (WT_ON,
145.6±18.3 µm; WT_OFF, 142±14.7 µm; CatCh_ON, 388.1±82.7 µm;
and CatCh_OFF, 182.3±29.6 µm). We measured and confirmed axon 
growth of GFP-labeled MNs (Fig. 4.5B) and quantified it (Fig 4.7B, right 
panel). Taken together, we identified that the optically evoked neural 
activity promotes axon growth of MNs.
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Figure 4.5. Axon growth of CatCh-MN by optogenetic stimulation.
(A) Schematic procedure of sample preparation to analyze axon length 
after MNs were transfected and stimulated by blue light before fixation 
for immunostaining. (B) CatCh-MNs treated with blue light were 
immunostained with TuJ1 to visualize the axon at DIV 5. Arrow (red) 
indicates GFP co-labeled MN, magnified in the red dotted box inset. 
Axon length of MNs was measured using ImageJ software, and 
compared between control MN with or without optical stimulation and 
CatCh-MN with or without optical stimulation. Each bar represents mean 
± S.E. value. n=5, 50 axons/each group; ***p < 0.001; Scale bar, 100 µm.
81
D. Optogenetic upregulation of intracellular cAMP and 
PKA
Previous studies have reported that elevated intracellular cAMP levels 
are sufficient to induce axon outgrowth and branching as well as 
neuronal viability.64,78-81 Thus, we next examined whether optically 
induced activity triggered axon growth-related cell signaling.
Intracellular cAMP and PKA levels of MNs at 1, 6, 24, 48 hours after 
optical stimulation were measured in comparison with control. As 
expected, optically stimulated CatCh-MNs showed upregulated 
intracellular cAMP as well as PKA expression levels after stimulation, 
whereas cAMP and PKA expression levels of optical stimulated WT-
MNs were low (Figs. 4.6A and B). Furthermore, our results demonstrate 
that the PKA downstream of cAMP regulates axon extension after optical 
stimulation as previously described.78 Schematic representation of the 
mechanism by which lower intensity of optical stimulation stimulates 
axonal extension is shown in Fig. 1.4. Optical stimulation upregulates 
intracellular cAMP via PKA, which might lead to transcription and 
translation of axon growth-associated factors.
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Figure 4.6. Intracellular level of cAMP (B) and PKA (C) expression 
in 2-D MN culture under optogenetic stimulation. (A) Schematic 
procedure of sample preparation to analyze protein expression after 
optogenetic stimulation. Intracellular levels of cAMP and PKA were 
measured using ELISA at 0, 1, 24, and 48 hrs after optical stimulation. 
As expected, cAMP and PKA expression in CatCh-MN were upregulated, 
as compared to those of WT-MN, as early as 1 hr post-stimulation. Each 
bar represents mean ± S.E. value. n=3; **p < 0.01, ***p < 0.001.
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Chapter V. 
3-D Coculture Model of MN-SC in 
Microfluidic Biochip
1. Introduction
With recent advances in micro-fabrication technology using bio-friendly 
polymers, such as polydimethylsiloxane (PDMS), researchers have 
introduced various microfluidic platforms, which allow in vitro studies 
on certain controlled characteristics of axon growth, injury and 
regeneration of neurons with or without glia cells. Jeon and his 
colleagues14,19,22 presented a microfluidic culture chamber in which axon 
compartment can be separated from cell soma and studied the outgrowth 
of neuronal axon independent of neuronal somata.  More recently, Park 
et al.20,21 introduced a multi-compartmentalized microfluidic culture 
device for coculture of cortical neurons and oligodendrocytes to study 
myelination process of CNS neurons.  Kamm and his colleagues82,83
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introduced a neuromuscular junction model on a compartmentalized 
microfluidic device, which consisted of myoblast-derived muscle cells 
and embryonic stem cell-derived MNs.
In Chapter V, a 3-D MN-SC coculture model with microfluidic chambers, 
which allows a separation between MN and SC cultures and yet 
maintains interactions between the two cell types. We also have utilized 
optogenetics to achieve a cell-type specific emulation of ES, similar to a 
previous work by Park et al.44 By incorporating genetically encoded 
opsin for cation channels into neurons, optogenetics allows optical 
stimulation of the cell to activate action potentials in the optogenetically 
transfected neurons.77 In our study, we used CatCh, an ultra-light 
sensitive Ca2+ permeable variant of channelrhodopsin-2,72 which allows a 
low light activation of action potentials in neurons. Using the 3-D 
hydrogel microfluidic chamber, we also investigated the effects of 
coenzyme Q10 on the MN myelination, which previously demonstrated 
an ability to accelerate myelination process in 2-D MN-SC coculture.45
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2. Materials and Methods
A. Fabrication of microfluidic biochip
The master mold was fabricated on silicon wafer by using 
photolithography with SU-8, the negative photoresist (MicroChem, 
USA). After fabricating master mold, polydimethylsiloxane (Sylgard 184, 
Dow Corning, USA) made of a 10 : 1 (w/w) mixture of PDMS base and 
curing agent was poured on the master mold and cured for 30 min in 
95˚C.  The cured PDMS was peeled off from the master mold.  Hydrogel 
injection ports and the reservoirs for cell culture medium were punched 
out with biopsy punches.  The PDMS device was permanently adhered to 
a sterilized glass coverslip by air plasma.  After bonding, the PDMS 
device was cured in 85˚C dry oven for a week to restore hydrophobicity. 
The PDMS device was sterilized by UV irradiation before experiment.
B. MN-SC coculture on biochips
3-D MN-SC coculture was first carried out in a mixture of collagen type 
I and Matrigel (1:1) in the microchannel regions of the microfluidic 
device. The gel was then incubated to polymerize for 20 min at room 
temperature and reservoirs were filled with culture medium, and the 
medium was drained from the opposite reservoir by suction to produce 
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hydrophilic surfaces in all medium channels. The devices filled with gel 
were tilted to align the gel at 90 degrees angle for 16 hrs and kept in 
37°C incubator prior to cell seeding. SC suspensions (3x106 cells/mL) 
were injected into the right reservoir of the microfluidic device, and the 
device was tilted to allow cells to adhere near gel surface for 30 min at 
90 degrees angle. After 24 hrs, MN suspensions (2x106 cells/mL) were 
again placed in the opposite reservoir of the device and tilted at 90 
degrees angle until the attachment of MN to the gel surface. Coculture 
cells in the device were cultured with neurobasal medium consisting of 
2~10% HS, B27 supplement, 0.5 mM L-gln, 0.5~1 mM β-
mercaptoethanol, 0.5 μM forskolin, 1 mg/mL bovine pituitary extract, 10 
ng/mL BDNF) for 7 days, after which 25~ 0 μg/mL of ascorbic acid 
(Sigma) was added for the subsequent culture as previously described.45
Medium was replenished four times a week.
C. Quantitative analysis of pre-myelinating and myelinating 
Schwann cells
For MBP or TuJ1 expression level analysis, each individual fluorescence 
image under the same condition of confocal microscopy was converted 
to a grayscale image. The integrated surface plot of fluorescence 
intensity (i.e., integrated intensity plot) associated with each protein was 
then acquired over the entire gel region in the biochip using ImageJ and 
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quantified. The samples were analyzed at DIV10, which corresponds to a 
pre-myelinating phase and DIV20, which corresponds to a myelinating 
phase, respectively (n=3).
D. Statistical analysis
Average data were shown as mean ± standard error, and the comparison 
between different groups was performed by using repeated measures 
analysis of variance (ANOVA). Statistical significance was set at a value 
of *p < 0.05, **p < 0.01, ***p < 0.001.
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3. Results
A. Establishment of 3-D MN-SC coculture model in the 
biochips
We used a microfluidic biochip that consisted of three distinct 
microfluidic channels: one channel for MN culture, another for SC 
culture, and a central channel interposed between the two cell-culture 
channels. The central channel was filled with a mixture gel of collagen-
Matrigel that separated the MN and SC culture, and provided a 3-D
microenvironment for axon growth and myelination of MN (Fig. 5.1). To 
form 3-D MN-SC coculture model, we received the microfluidic 
biochips from NL Jeon’s laboratory at the Seoul National University, and 
carried out the procedure according to the Bang et al.22 study. Briefly, the 
microfluidic biochips have composed of three distinct channels including 
MNs, SCs, and gel channels (Fig. 5.1A). In particular, gel channels of 
these biochips are useful to extend axons regularly toward opposite
direction. The mixture gel (collagen:Matrigel, 1:1)-filled gel channel in 
the biochips was tilted at 90 degrees angle to induce the hydrostatic 
pressure generated by the medium added in the reservoirs. This allowed a 
uniform alignment in polymerizing gels (Fig. 5.1B).
After gel loading, SCs, which were suspended in 50 µL of SC medium, 
were added to the microfluidic biochips. The hydrostatic pressure that 
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was induced in biochips, tilted at 90 degrees, generated a continuous 
fluid flow that distributed SCs to attach to the surface of gel channel. 
MNs were also loaded in other reservoirs after SC seeding, and the 
biochips were tilted at 90 degrees for 30 min to allow MNs to adhere 
near the surface of the gel channel. Prior to cell loading, alignment of the 
mixture gel in the gel channel supported a more uniform distribution of 
cells, which induced uniform axon growth towards the opposite channel,
and generated migration of SCs evenly (Fig. 5.2). Furthermore, the 
structure of gel-filled channel in the microfluidic biochips provided a
culture of distinct cell populations and allowed the transfection of MNs 
only. pCatCh-EYFP were transfected to MNs using lipofectamine
reagent in the MN reservoirs before axons of MN interacted with SCs,
and expression of pCatCh was confined to MNs in the MN reservoirs 
that received the pCatCh transfection. GFP expression was seen in MNs 
in MN channel, but not other SC channel (Fig. 5.2, top panel). On DIV 4, 
transfected MNs were optically stimulated to trigger axon growth, and 
treated with coenzyme Q10 (Co-Q10) to activate the myelin process. We 
examine the detailed myelin stages at DIV 10 and 20.
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Figure 5.1. 3-D MN-SC coculture model on microfluidic biochip; (A) 
Microfluidic biochip consists of five distinct channels separated by four 
micropillar arrays; three central channels for hydrogel formation, one 
channel for SC culture, and one channel for MN culture. (B) On DIV-2, 
three central channels were filled with a 1:1 mixture of collagen and 
Matrigel at 4˚C, and a hydrostatic pressure created by 90˙ vertical tilt 
method was applied onto the mixture gel during gelation process in 37˚C 
incubator in order to create a patterned cross-linking density distribution 
in the hydrogel. SC and MN were then seeded and attached using vertical 
tilt method onto the gel surface in the respective cell culture channel on 
DIV-1 and DIV0, respectively. 
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Figure 5.2. Temporal flowchart describing the protocols of 3-D MN-
SC coculture study. Microscopic images of 3-D MN-SC coculture 
biochip are shown at different time points. At DIV 2, the gel channel was 
filled with a collagen-Matrigel (1:1) mixture. SCs and MNs were seeded 
through cell-seeding reservoirs at DIV 1 and DIV 0, respectively. On the 
second day after MN seeding (DIV 2), pCatCh (5 µg) with lipofectamine
was loaded into MN channel. Fluorescent microscopic image at DIV 3 
confirmed CatCh-transfected MNs. Note in the microscopic image that 
CatCh transfection was visible only in the MN region, not in the SC 
region. The MN-SC coculture biochip was examined for MBP-
expression at DIV 10 (pre-myelinating stage) and at DIV 20 (myelinating 
stage), respectively. Scale bar, 100 µm.
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B. Axon growth by optical stimulation
We first examined the axon growth on 3-D microfluidic biochip in which 
axons grow uniformly regularly towards the opposite channel, and that 
can serve as quantitative analysis for growing axons. We observed the 
effect of optical stimulation on the axons of MN, extended into the gel 
channel of biochip, as assessed by immunocytochemistry (Fig. 5.3, left 
panel). At DIV 5, optically excitable CatCh-MN axons significantly
increased (694.4 ± 17.7 µm) and the length was 2.1-fold longer than that 
of control (333.8 ± 17.1 µm) (Fig. 5.3, right panel). We confirmed the 
effect of optical stimulation on axon growth in both 2-D and 3-D
formation of MNs. 
In MN-SC 3-D model, we examined the axon growth in each group 
using immunocytochemistry, and quantified it at DIV10 and 20. 
However, optogenetic stimulation did not affect axon growth in MN-SC 
coculture model. At DIV 10, axon growth of all groups were already
elongated to the opposite channel of SCs, and there was no difference in
axon growth in each group analyzed by the pixel intensity of TuJ1
stained-axons (Control, 630.2 ±14 µm; Optstim., 672.3 ± 8 µm; Co-Q10,
624.2 ± 23.6 µm; Optstim.+Co-Q10, 696.9 ± 7.4 µm). In addition, at 
DIV20, we did not observe the benefit of optogenetic stimulation in 2-D
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MN culture (Control, 694.2 ± 5 µm; Optstim., 704.3 ± 14.5 µm; Co-Q10,
690.1 ± 21.8 µm; Optstim.+Co-Q10, 744.9 ± 15.9 µm). 
Figure 5.3. Axon growth of MN monoculture in 3-D microfluidic 
biochip with (CatCh-MN, positive control) or without (wild type MN, 
negative control) optical stimulation. (A) TuJ1 stained images of MN 
axons for negative control and positive control on DIV 5. (Scale bar, 100 
mm) (B) The length of TuJ1-stained axons was quantified using ImageJ 
software. CatCh-MN under optical stimulation produced significantly 
increased axon length, as compared to WT-MN without optical 
stimulation. Error bars indicate S.E. (n=3, total 30 axons)
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Figure 5.4. Effects of optogenetic stimulation and/or Co-Q10 
treatment on axon growth of MN in 3-D MN-SC coculture model.
The pixel intensity of TuJ1-stained axons of each group was measured by 
ImageJ (A-C) on DIV10, (D-F) on DIV20. Representative confocal 
images (A and D) and the intensity distribution (B and E) of TuJ1
expression in MN-SC coculture biochip, in which TuJ1 and DAPI were 
shown in red and blue, respectively. (C and E) Quantitative results of the 
integrated pixel intensity of MBP expression. No significant differences 
were found by One Way ANOVA. Each bar represents mean ± S.E. value 
(n=3, 5 random regions).
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C. Two distinct stages of myelination in biochips
SCs in the PNS have significant functions to support neurons including 
dorsal-root ganglia (DRGs) and MNs, which express neurotrophic
factors such as nerve growth factor (NGF),55 brain- derived neurotrophic
factor (BDNF),58 and ciliary neurotrophic factor (CNTF)26 to promote 
axon growth and viability of neurons. Furthermore, SCs are particularly 
important in myelination of axons of neurons in PNS, wherein wrapping 
of neurons by SCs increases the speed at which impulses are conducted. 
In our study, we next examined the myelin process in the microfluidic 
biochip to validate our microfluidic biochips as a 3-D coculture platform. 
We identified distinct stages of MBP expression at DIV 10 (Figs. 5.5A-C)
and DIV 20 (Figs. 5.5D-F). We classified the myelin process, which 
could be distinguished on basis of MBP expression pattern as described 
previously.45 We identified that in the pre-myelinating stage, coculture 
model with Co-Q10 extensively expressed MBP in SCs, whereas we did 
not detect MBP expression in coculture model without Co-Q10 at DIV10 
(Figs. 5.5A and B).
However, in myelinating stages, MBP expression by SCs eventually 
became highly localized around axons similarly in all group of the 
microfluidic biochips (Fig. 5.5D and E, and Fig. 5.6). We observed that 
myelin sheaths of 3-D form were aligned along the MN axons, which 
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mimicked the in-vivo condition in MN-SC coculture model (Fig. 5.6, 
yellow dotted boxed/each group). In addition, we calculated the 
integrated pixel intensity of MBP expression at distinct two stages 
quantitatively (Fig. 5.6C and F). We confirmed that Co-Q10 is a
significant activator that promotes MBP expression rapidly at DIV10, 
which can be useful to stimulate SC differentiation against myelin 
process in SC development.
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Figure 5.5. Effects of optogenetic stimulation and/or Co-Q10 
treatment on MBP expression of MN in 3-D MN-SC coculture model.
Representative confocal images (A and D) and the intensity distribution 
(B and E) of MBP expression of MN-SC coculture biochip, in which 
MBP and DAPI are shown in green and blue, respectively. Note that 
MBP expression was widespread in the culture in pre-myelinating stage 
(A), but aligned tightly along the MN axons in myelinating stage (D). 
Quantitative results of the integrated pixel intensity of MBP expression 
were presented in (C) and (F). Each bar represents mean ± S.E. value. 
(n=3, 5 random regions; ***p < 0.001; Scale bar, 100 µm.
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Figure 5.6. Representative 3-D reconstruction image of MN-SC 
coculture on the biochip. The culture was immunostained with TuJ1
(red), MBP (green) and DAPI (blue) (control, OptStim, Co-Q10, and 
OptStim + Co-Q10). All biochips showed abundant MBP expression, and 
highly myelinated axons were visible in high magnification images 
(yellow dot boxes/each group). Scale bar, 25 µm.
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Chapter VI.
Discussion and Conclusion            
1. Discussion
Several in vitro models have been previously developed to study the 
cellular and molecular mechanisms involved in the myelination process. 
Sensory neurons from dorsal root ganglia12,13,84,85 and retinal ganglia86
have been cocultured with SCs to induce the formation of myelin sheath 
in vitro. Several in vitro models for MN culture have also been 
introduced,16,17,19,27,47 and the findings from these studies have confirmed 
that addition of exogenous neurotrophic supplements and/or a coculture 
with SCs or fibroblasts was critical for the survival and neurite 
outgrowth of MNs cultured in vitro. MN cultures treated with astrocyte-
conditioned medium87 or insulin-like growth factor-127 could specifically 
enhance the extent and rate of axonal outgrowth from murine 
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corticospinal MNs. However, to the best of our knowledge, no culture 
method to date has recapitulated the myelination process of MN by SCs 
in vitro. Moreover, previous studies have attempted to culture MNs by 
using NycoPrepTM, OptiPrepTM, or immunopanning dishes, but the 
purified MNs frequently failed to survive long-term.17,47,88 In this study, 
we have aimed at constructing a MN-SC coculture system to model both 
the axon outgrowth and the myelination process of MN. 
Here, we confirmed that SCs play an essential role in increasing the 
viability and promoting axonal outgrowth of MNs. Consistent with our 
results, several groups have reported that SCs enhance long-term 
viability of peripheral neurons and protect the axonal integrity. Meyer zu 
Horste et al.89 reported that dysfunction of SCs leads to peripheral 
neuropathies, and Viader et al.90 found that mitochondrial function in 
SCs is essential not only for neuronal survival but also for normal 
function of peripheral nerves. Similarly, glial cells have been shown to 
play a vital role for the growth and stability of developing synaptic 
structure as well as for proper functioning of neuromuscular junction.91
With regard to nerve injury, it is well documented that SCs play a role in 
promoting recovery of the injured PNS by providing beneficial 
environment to the injured neurons.92,93 SCs de-differentiate, proliferate, 
and form Bands of Büngner at the injury site, by which they guide the 
regrowth of the proximal axons towards the target.94 Our results, along 
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with the previous reports, support the notion that SCs play an essential 
role in controlling the viability, axon growth, and perhaps the functions 
of MNs.
In addition, we confirmed neurotrophic effects of protein secreted from 
SCs by using transwell that enabled separation between MNs and SCs 
culture in the same medium, which consequently promoted the viability 
and axon growth of MNs, and inhibited the effects by adding SLPI. In 
particular, we identified the loss of about 46% by SLPI on MNs viability 
at DIV 14 (Fig. 3.1), suggesting that PGRN are necessary to maintain 
MN survival and the remaining viability of MNs might be influenced by 
other neurotrophic factors secreted from SCs as previously 
described.23,25,58
PGRN has been recently demonstrated to play a key role in several fields, 
including cancer models such as bladder,95 breast, hepatocellular 
carcinomas, and neurodegenerative disease such as FTLD and ALS.96
Furthermore, several laboratories have demonstrated a critical role of 
PGRN derived from specific types of cells, including adipose-derived 
stem cells97 and human mesothelioma cells.33 PGRN secreted from cells 
not only induces the differentiation of retinal precursor cells to 
photoreceptor cells97 but also promotes supernatant-induced tube 
formation33 when tissue is damaged. These results are consistent with our 
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finding that PGRN is a secreted growth factor derived from SCs and 
serve as regulator of MN growth. 
Notably, we confirmed the effect of PGRN on MN viability wherein
PGRN and GRN fragments sustained MNs without SCs for at least 2 
weeks (Fig. 3.6). We also found that MNs are more vulnerable to attack 
by environment, and MNs viability could not prolong after day 10 in 
MNs monoculture. These findings suggest that PGRN is a powerful 
neurotrophic factor for maintenance of MN viability,34,35 and might be 
useful a biochemical candidate for therapeutic trial in disease model of 
motor neuron with ALS and FTLD.96
In addition, other than the neurotrophic factors, external stimulation has 
been known to have an effect on axon growth in developing neurons.37,44
Here, we used optogenetics to induce axon growth of MNs, which takes 
advantages of high conductance and the fast kinetics of optogene that 
allows activation of axon growth-related proteins. Unlike electrical 
stimulation, optogenetic stimulation can be genetically targeted to allow 
exploring of specific neurons, avoiding the simultaneous activation of 
multiple cell types. However, rapid cell death of MNs occurs when 
optically sensitive MNs are excited by LED stimulator at intensity of 5
mW/mm2 or above, while other types of neurons44 were activated at 
intensity of 5~7 mw/mm2. Therefore, CatCh is prerequisite for 
researching optical activity of MNs, which is ~70 fold more light 
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sensitive than wild type.72 When optically sensitive CatCh-MNs are 
stimulated at intensity of low level (1 mW/mm2 or under), axon growth 
of MNs exhibited a ~2.6-fold increase in length compared to WT MNs. 
Furthermore, these results have demonstrated elevated cAMP and PKA 
expression level after stimulation. Consistent with our previous ELISA 
results, Aglah et. al.78 reported that PKA, downstream of cAMP, controls 
neurite outgrowth and elongation of MNs on a permissive substrate.
Our culture enables monitoring of the pre-myelinating and myelinating 
stages of SCs in vitro. Signals released from SCs are critical for 
myelination of peripheral nerve fibers.48 NRG1 (neuregulin) in the 
axonal membrane is essential for initiating the myelination process by 
binding to ErbB (erythroblastic leukemia viral oncogene homolog) 
family receptors expressed in SCs, and SC-derived signals are thought to 
primarily control the wrapping process of myelin around the axon. 
Among them, Krox20/Egr2 (early growth response-2), which functions 
downstream of Sox10 (SRY-related HMGbox-10) and is activated by 
Oct6 (octamer-binding transcription factor-6), is essential for activating a 
number of myelin genes and maintaining the myelinated state by 
blocking inhibitors of myelination. Our results in Fig. 2.7 show that
Sox10 expression at DIV 7 preceded MBP expression, which was 
observed at DIV 10. The results in Fig. 2.8 also show a gradual increase 
of Krox20 first detected on DIV 7, followed by a strong expression at a 
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later stage (DIV 21). At later stages, MBP was highly localized along the 
axon fibers (Fig. 2.9). Our findings are consistent with the well-
documented hierarchy of SC transcription factors controlling myelination 
(reviewed by Pereira et al.48). In our culture, we were able to confirm the 
sequential process of myelination, which was initiated by migration of 
SCs toward axons, followed by further differentiation of SCs, as 
evidenced by increased expression of MBP. Finally, SCs wrapped around 
axons, leading to the formation of thick myelin sheaths.
In the present study, we examined the efficacy of two candidate drugs, 
which might promote myelination of nerve fibers. We tested the effect of 
riluzole, a drug that is thought to protect neurons by decreasing the level 
of glutamate, and approved by FDA and clinically used for the treatment 
of ALS.98 We also tested the effect of Co-Q10, a vitamin-like antioxidant 
substance that enhances ATP production in mitochondria. We found that 
while riluzole had no significant effect on myelination of MN axon fiber, 
Co-Q10 facilitated MBP expression and enhanced myelination. Lack of
positive effect of riluzole confirmed in our study could be explained 
within the context of the controversy about the efficacy of riluzole 
treatment of ALS.99 SCs treated with Co-Q10 expressed MBP at an 
earlier stage (DIV 7), implying that Co-Q10 might accelerate 
myelination of nerve fibers. MNs seem to have higher energy demand 
and metabolic rate due to their increased mitochondrial activity in 
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comparison to other neurons.46 The stimulating effect of Co-Q10 found 
in our study could be due to its ATP synthesizing ability as electron 
carriers100 or the antioxidant nature of Co-Q10,101,102 or a combination of 
both. The exact mechanism and efficacy of Co-Q10 warrants further 
studies.
In the last chapter, we discussed a 3-D MN-SC coculture model in 
microfluidic devices that are helpful to allow uniform directional growth 
of axons by regularly aligned pores in gel. These chips have a fascinating 
advantage that enables quantitative analysis of axon growth and detailed 
examination of MN-SC interaction in 3-D formation. We also applied 
various factors on to the model for promotion of the axon generation and 
myelination. However, when MNs were cocultured with SCs, we did not 
observe optogenetic effects on axon growth of MNs while MNs were 
only cultured without SCs. Previous studies reported that SC is a 
powerful source, which can maintain the viability of MNs for more than 
3 weeks and increase axon growth, about 4 fold times more in length 
than MN monoculture without SCs.45 Because MN axons were strongly 
elongated by SCs already before anticipating the growth effect by 
optogenetic stimulation, we did not observe the dramatic effect of 
optogenetic stimulation on MN-SC coculture (Fig. 5.4). However, the 
result (Fig. 5.3), where MN axons without SCs in microfluidic biochips 
were promoted by optogenetic stimulation is consistent with 2-D model 
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as previously mentioned in chapter III. In addition, we expected to 
promote myelin process by optogenetic stimulation that has the same 
principle as electrical stimulation for inducing the action potential in 
neurons. Similar to axon growth induced by electrical stimulation,10,36,78
we identified increase in axon length by optogenetic stimulation through 
elevated cAMP and PKA expression level compared with that of control
(Fig. 4.8).
In addition, we also examined the other functions of optogenetic 
stimulation, that is myelination. But our studies did not show the 
promotion of myelin process with optogenetic stimulation. However,
regulation of myelination by electrical stimulation remains controversial. 
Several laboratories reported103 that impulse activity by electrical 
stimulation might have a critical influence on myelination in CNS and 
PNS, but there are some differences between the published reports. Zalc 
group103 claimed that impulse activity in axons is necessary for initiating 
myelination in CNS. They reported that oligodendrocytes, which are the
glial cells of CNS were proliferated and differentiated by electrical 
stimulation in the absence of neurons in vitro, which can wrap around 
themselves to form myelin-like formations or adhere to carbon fibers to 
promote myelination. In contrast, Fields group103 reported that DRGs in 
PNS did not influence and inhibit myelination by frequency-specific 
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effects of electrical stimulation, wherein low frequency stimulation (0.1 
Hz) could induce decrease in the amount of LI, one of the neuronal cell 
adhesion molecules (CAMs) in the axonal membrane, that have a critical 
role in initiation of myelination. However, other frequencies of electrical 
stimulation (1 Hz) induced myelination in DRGs, but these impulse 
activity influencing myelination might differ in different types of neurons
with different firing patterns as well as different stages of myelination, 
including premyelinating SCs and myelinating SCs in development. 
Furthermore, the number of SCs was not different in electrically
stimulated or unstimulated cultures unlike oligodendrocyte in CNS. To 
resolve myelination of MN-SC coculture model with optogenetic 
stimulation, further studies are needed taking into consideration the 
timing of optogenetic stimulation, premyelination stage and/or 
myelinating stage, and frequency of stimulation, similar to impulse 
activity of MNs.
However, In any rate, it seems clear that the beneficial effect of CoQ10 
during early-stage myelination process, which was previously reported in 
2-D MN-SC coculture model by Hyung et al.,45 was still realized in the 
present 3-D MN-SC coculture model.
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2. Conclusion
In this dissertation, we presented a simple and reproducible 2-D and 3-D
MN-SC coculture models to study the axon growth and myelination 
process of MNs in the presence of SCs. First, using a 2-D coculture of 
MNs and SCs, we found that SC plays a vital role in providing proper 
environment for the biological fate of MN, such as cellular viability, 
axon growth, and myelination. We also found that PGRN secreted by 
SCs could be a potential neurotrophic factor for MNs for improving the
viability and axon growth of MN. In addition, we reported that 
optogenetic stimulation alone could improve the axon outgrowth of MNs
in the absence of SCs. We also presented that Co-Q10 can be used to 
accelerate myelination process of MN in the presence of SCs. We finally 
presented a microfluidic biochip model as a 3-D MN-SC coculture 
platform to mimic 3-D microenvironment for axon development and 
myelination of MN.
In conclusion, in vitro 2-D and 3-D MN-SC coculture models presented 
in this dissertation help us to understand the interactions between MNs 
and SCs in terms of axon regeneration and myelination of MN. We 
believe that these models can be used in the future as an ex vivo tool to 
understand the mechanisms of motor neuron diseases such as 
amyotrophic lateral sclerosis (ALS) as well as of repair of damaged 
motor neurons.
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Abstract (in korean)
운동신경과 슈반세포 공동 배양 모델에서의 축삭 성장과 수초
형성
<지도교수 박종철>
연세대대학교 대학원 의과학과
형수진
신경시스템에서 수초의 형성은 축삭 주위를 둘러싸고 있는 중요한
구조로 수초형성에 의해 빠른 신경도약을 가능하게 하는
절연체이다. 중추신경계에서는 희돌기신경교, 말초신경계에서는
슈반세포가 축삭 주위를 감싸는데, 중추신경계의 희돌기신경교는
세포질을 이용하여 여러 신경세포의 축삭을 둘러쌓는 반면, 
말초신경계의 슈반세포는 세포체 전체가 하나의 슈반세포가
하나의 신경세포 축삭의 일부분을 감싸고 있는 차이가 있다. 이러한
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신경계에서 손상을 받으면 지금까지는 중추신경계에서는 재생이
불가능하고 말초신경계에서는 손상 후 재생이 이루어 진다고 보고
되어 왔지만 이러한 말초신경계의 재생도 환자의 나이, 손상의 정도, 
재생의 환경에 의해 크게 좌우된다. 많은 문헌에서는 손상모델 뿐만
아니라 질환모델에서 신경재생을 위한 연구를 진행하고 있지만
아직까지 명확하게 해결책을 찾지 못했고, 여러가지 재생의
한계점을 풀지 못했다. 이 논문에서는 이러한 한계점을 극복하기
위해 신경계 중 움직임을 조절하는 운동신경계의 이차원적과
삼차원적인 in vitro 모델을 확립하고 여기에 축삭의 성장과
수초형셩을 촉진시키는 요인을 연구하고자 한다. 먼저, 이차원적
운동신경모델의 형성으로 운동신경과 슈반세포의 상호작용을
이해하고 그 다음 microfluidic 바이오칩을 이용하여 삼차원적인 in 
vitro 모델 형성으로 in vivo 와 유사한 환경을 재현하였다. 지금까지
알려진 운동신경은 배양했을 때 일주일 이상 그 생존율을 지속하기
어렵다. 하지만 슈반세포와의 공동배양을 통해 운동신경의
생존율은 한 달간 지속 되었다. 이 기간 동안 슈반세포는
운동신경의 생존 뿐만 아니라 축삭의 성장까지 증가시켰다. 이러한
슈반세포의 효과는 슈반세포에서 분비하는 7.5 개의 granulins (GRN)
로 이루어진 Progranulin (PGRN)이라는 단백질에 의해서 조절되고
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그 중  GRN C 와 E 가 강력한 neurotrophic 요소로서 슈반세포가
없는 상태에서 운동신경세포의 생존을 이주 이상 지속시켰다. 또한
우리는 광유전자를 이용하여 운동신경 축삭의 성장을
촉진시키는데 그 방법을 확립하였다. 게다가 슈반세포는 수초를
형성하는 중요한 세포로서 이 논문에서는 슈반세포의 수초형성
과정을 정량적으로 측정하였고 이 공동배양 모델을 통해 coenzyme 
Q10 이 수초형성을 촉진시키는 약물인 점을 확인 할 수 있었다. 
이러한 공동배양 모델은 앞에서 언급한 운동신경 재생의 한계점을
극복하는데 중요한 도구로 사용 될 수 있다. 또한 수초형성
메카니즘을 분석하고고 ALS 와 같은 운동신경 질환을 연구하는데
약물 스크리닝을 할 수 있는 도구로서도 도움을 준다. 그 뿐만
아니라 in vivo 모사 in vitro 모델은, 손상 후 재생의 한계점을 밝혀혀
세포간의 정밀한 메카니즘을 연구하는데 용이하다.
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